InsiderClue
Insiders · Profile

HENDERSON MICHAEL THOMAS

Chief Executive Officer at Apogee Therapeutics · Director at Spyre Therapeutics · Chief Business Officer at BridgeBio Pharma. Filing since 1 Jul 2019. CIK 0001779990

APGE Apogee Therapeutics, Inc. Chief Executive Officer · 20 trades SYRE Spyre Therapeutics, Inc. Director · 2 trades BBIO BridgeBio Pharma, Inc. Chief Business Officer · 20 trades
Company
Date
Role
Action
Shares
Amount
Of holding
APGE Apogee Therapeutics, Inc.
8 Jul 2026
Chief Executive Officer
Sold on a plan
20,000
$2.67M
2.0%
APGE Apogee Therapeutics, Inc.
22 Jun 2026
Chief Executive Officer
Sold on a plan
80,000
$10.60M
7.3%
SYRE Spyre Therapeutics, Inc.
22 Jun 2026
Director
Sold on a plan
20,000
$2.00M
22.6%
APGE Apogee Therapeutics, Inc.
10 Jun 2026
Chief Executive Officer
Sold on a plan
20,000
$1.67M
1.8%
APGE Apogee Therapeutics, Inc.
13 May 2026
Chief Executive Officer
Sold on a plan
20,000
$1.64M
1.8%
SYRE Spyre Therapeutics, Inc.
8 May 2026
Director
Sold on a plan
80,000
$5.95M
47.4%
APGE Apogee Therapeutics, Inc.
8 Apr 2026
Chief Executive Officer
Sold on a plan
20,000
$1.65M
1.7%
APGE Apogee Therapeutics, Inc.
11 Mar 2026
Chief Executive Officer
Sold on a plan
20,000
$1.50M
1.7%
APGE Apogee Therapeutics, Inc.
11 Feb 2026
Chief Executive Officer
Sold on a plan
20,000
$1.27M
1.7%
APGE Apogee Therapeutics, Inc.
14 Jan 2026
Chief Executive Officer
Sold on a plan
20,000
$1.62M
1.6%
APGE Apogee Therapeutics, Inc.
10 Dec 2025
Chief Executive Officer
Sold on a plan
20,000
$1.51M
1.6%
APGE Apogee Therapeutics, Inc.
4 Dec 2025
Chief Executive Officer
Sold on a plan
40,000
$3.00M
3.1%
APGE Apogee Therapeutics, Inc.
13 Nov 2025
Chief Executive Officer
Sold on a plan
20,000
$1.26M
1.5%
APGE Apogee Therapeutics, Inc.
5 Mar 2025
Chief Executive Officer
Sold on a plan
10,000
$301.51K
0.8%
APGE Apogee Therapeutics, Inc.
5 Feb 2025
Chief Executive Officer
Sold on a plan
15,000
$608.70K
1.1%
APGE Apogee Therapeutics, Inc.
8 Jan 2025
Chief Executive Officer
Sold on a plan
15,000
$732.69K
1.1%
APGE Apogee Therapeutics, Inc.
4 Dec 2024
Chief Executive Officer
Sold on a plan
15,000
$698.65K
1.1%
APGE Apogee Therapeutics, Inc.
6 Nov 2024
Chief Executive Officer
Sold on a plan
15,000
$888.32K
1.1%
APGE Apogee Therapeutics, Inc.
2 Oct 2024
Chief Executive Officer
Sold on a plan
40,000
$2.25M
2.9%
APGE Apogee Therapeutics, Inc.
4 Sep 2024
Chief Executive Officer
Sold on a plan
40,000
$1.90M
2.8%
APGE Apogee Therapeutics, Inc.
7 Aug 2024
Chief Executive Officer
Sold on a plan
40,000
$1.62M
2.7%
APGE Apogee Therapeutics, Inc.
5 Jul 2024
Chief Executive Officer
Sold on a plan
15,000
$558.90K
1.0%
BBIO BridgeBio Pharma, Inc.
1 Dec 2020
Chief Business Officer
Sold, plan not stated
10,000
$515.20K
3.5%
BBIO BridgeBio Pharma, Inc.
16 Nov 2020
Chief Business Officer
Sold, plan not stated
10,000
$450.00K
3.6%
BBIO BridgeBio Pharma, Inc.
2 Nov 2020
Chief Business Officer
Sold, plan not stated
10,000
$383.56K
3.6%
BBIO BridgeBio Pharma, Inc.
1 Oct 2020
Chief Business Officer
Sold, plan not stated
10,000
$388.34K
3.6%
BBIO BridgeBio Pharma, Inc.
18 Sep 2020
Chief Business Officer
Sold, plan not stated
10,000
$400.00K
3.6%
BBIO BridgeBio Pharma, Inc.
1 Sep 2020
Chief Business Officer
Sold, plan not stated
10,000
$287.33K
3.6%
BBIO BridgeBio Pharma, Inc.
3 Aug 2020
Chief Business Officer
Sold, plan not stated
10,000
$273.74K
3.7%
BBIO BridgeBio Pharma, Inc.
1 Jul 2020
Chief Business Officer
Sold, plan not stated
10,000
$309.70K
3.7%
BBIO BridgeBio Pharma, Inc.
8 Jun 2020
Chief Business Officer
Sold, plan not stated
606
$18.19K
0.2%
BBIO BridgeBio Pharma, Inc.
3 Jun 2020
Chief Business Officer
Sold, plan not stated
784
$23.55K
0.3%
BBIO BridgeBio Pharma, Inc.
1 Jun 2020
Chief Business Officer
Sold, plan not stated
2,585
$75.91K
1.0%
BBIO BridgeBio Pharma, Inc.
5 May 2020
See Remarks
Sold, plan not stated
1,460
$44.49K
0.9%
BBIO BridgeBio Pharma, Inc.
4 May 2020
See Remarks
Sold, plan not stated
1,320
$39.61K
0.8%
BBIO BridgeBio Pharma, Inc.
1 May 2020
See Remarks
Sold, plan not stated
2,585
$75.65K
1.5%
BBIO BridgeBio Pharma, Inc.
1 Apr 2020
See Remarks
Sold, plan not stated
2,585
$69.63K
1.5%
BBIO BridgeBio Pharma, Inc.
2 Mar 2020
See Remarks
Sold, plan not stated
3,975
$128.97K
2.3%
BBIO BridgeBio Pharma, Inc.
3 Feb 2020
See Remarks
Sold, plan not stated
3,975
$138.73K
2.2%
BBIO BridgeBio Pharma, Inc.
3 Jan 2020
See Remarks
Sold, plan not stated
358
$11.57K
0.2%
BBIO BridgeBio Pharma, Inc.
2 Jan 2020
See Remarks
Sold, plan not stated
3,617
$120.29K
2.0%
BBIO BridgeBio Pharma, Inc.
1 Jul 2019
See Remarks
Bought
7,000
$119.00K
4.0%
42 decisions on file.